Related Experiment Videos
Sera from MS patients and normal controls opsonize myelin
P Z Goldenberg1, R A Troiano, E E Kwon
1Department of Neurosciences, UMDNJ-New Jersey Medical School, Newark.
Neuroscience Letters
|February 16, 1990
Summary
Multiple sclerosis (MS) patients' sera do not show increased myelin opsonization compared to healthy controls. This suggests Fc receptor-dependent myelin phagocytosis may not be a primary driver of demyelination in MS.
Area of Science:
- Neuroimmunology
- Demyelinating Diseases
- Immunology
Background:
- Fc receptor-mediated phagocytosis of myelin is a proposed mechanism for demyelination in multiple sclerosis (MS).
- Understanding the role of serum opsonization in myelin phagocytosis is crucial for elucidating MS pathogenesis.
Purpose of the Study:
- To investigate whether serum from multiple sclerosis (MS) patients exhibits enhanced opsonization of myelin compared to serum from normal healthy controls.
- To assess the potential contribution of serum opsonization to myelin phagocytosis in the context of MS.
Main Methods:
- Murine peritoneal macrophages were cultured with radioiodinated (125I-labelled) bovine central myelin.
- Myelin was pre-sensitized with sera from MS patients and normal controls.
- Opsonization levels were quantified by measuring macrophage uptake of labelled myelin after 30 and 120 minutes.
Main Results:
- Both multiple sclerosis (MS) patient sera and normal control sera demonstrated equivalent myelin opsonization capabilities.
- No significant difference in the ability of sera to enhance myelin phagocytosis was observed between the two groups at either incubation time point.
Conclusions:
- Serum from MS patients is not more opsonic for myelin than serum from normal individuals.
- These findings do not support a role for increased serum opsonization of myelin as a mechanism driving demyelination in multiple sclerosis (MS).